Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Alcoholism Therapy
Research on alcoholism therapy reported by scientists at University Hospital, Department of Gastroenterology
April 6th, 2008
New investigation results, 'Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study,' are detailed in a study published in International Journal of Clinical Practice. According to a study from London, the United Kingdom, "Studies have shown that weight loss can have a favourable effect upon non-alcoholic fatty liver disease (NAFLD). However, the most effective means of achieving weight loss and safety profile of lipid-lowering drugs in the presence of NAFLD is unknown." "To investigate the effect of dietary advice and lipid-lowering drugs, particularly statins, on patients with NAFLD and dyslipidaemia....
Source: Pharma Investments, Ventures & Law Weekly (2008-04-06)
|
